150 related articles for article (PubMed ID: 29191582)
1. Patterns of care and survival among patients with malignant mesothelioma in the United States.
Enewold L; Sharon E; Thomas A
Lung Cancer; 2017 Oct; 112():102-108. PubMed ID: 29191582
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
[TBL] [Abstract][Full Text] [Related]
3. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
[TBL] [Abstract][Full Text] [Related]
4. Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
Taioli E; Wolf A; Alpert N; Rosenthal D; Flores R
J Surg Oncol; 2023 Jul; 128(1):134-141. PubMed ID: 36932968
[TBL] [Abstract][Full Text] [Related]
5. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
Saddoughi SA; Abdelsattar ZM; Blackmon SH
Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Survival among Male and Female Patients with Malignant Pleural Mesothelioma: A Random Survival Forest Analysis of Data from the 2000-2017 Surveillance, Epidemiology, and End Results Program.
Liu B; Niu L; Boscoe F; Lee FF
J Registry Manag; 2021; 48(3):118-125. PubMed ID: 35413729
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
Damhuis RA; Khakwani A; De Schutter H; Rich AL; Burgers JA; van Meerbeeck JP
Lung Cancer; 2015 Aug; 89(2):212-7. PubMed ID: 26044908
[TBL] [Abstract][Full Text] [Related]
9. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
[TBL] [Abstract][Full Text] [Related]
11. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural mesothelioma: a population-based study of survival.
Milano MT; Zhang H
J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
[TBL] [Abstract][Full Text] [Related]
13. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
14. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
[TBL] [Abstract][Full Text] [Related]
15. Differential Survival Characteristics of Sarcomatoid Subtype in Biphasic Pleural Mesothelioma.
Harling L; Kolokotroni SM; Nair A; Smelt J; King J; Routledge T; Spicer J; Ng W; Bille A
Ann Thorac Surg; 2019 Mar; 107(3):929-935. PubMed ID: 30389446
[TBL] [Abstract][Full Text] [Related]
16. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
[TBL] [Abstract][Full Text] [Related]
18. Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.
Abdel-Rahman O
Strahlenther Onkol; 2017 Apr; 193(4):276-284. PubMed ID: 28044200
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
Van Gerwen M; Alpert N; Wolf A; Ohri N; Lewis E; Rosenzweig KE; Flores R; Taioli E
Carcinogenesis; 2019 Jun; 40(4):529-536. PubMed ID: 30649229
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.
Bölükbas S; Eberlein M; Kudelin N; Demes M; Stallmann S; Fisseler-Eckhoff A; Schirren J
Eur J Cardiothorac Surg; 2013 Jul; 44(1):119-23. PubMed ID: 23242984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]